Ashul Govil, MD
Cardiovascular Disease (Cardiology) · Antioch
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 3
- Since medical school
- 17 years
- University of Virginia School of Medicine, 2009
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Sutter Delta Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Govil’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A126257 · Current
Licensed to practise in California · since 2013 · expires 2027-04-30 · University of Virginia School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Delta Medical CenterAntioch, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.173, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Delta Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.173 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.03) · 561 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.47 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 176.46 (114.75 to 238.17) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 260 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 1,274 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 3,285 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,374 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 364 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.49 to 3.83) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.63 (0 to 18.4) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.24 (0 to 1.07) · 2,713 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.962 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 116 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 316 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 20 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.1 · 298 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.3 · 269 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 283 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.7 to 17.1) · 529 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 45 cases | No different | Jan 2024 – Dec 2024 |
What patients said (610 patients answered, 13% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 64% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$17,232
Medicare paid this office $17,232 for 82 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $3,988 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,481 | $105 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,928 | $107 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
82 Original Medicare patients in 2024. Average age 76 · Women 49% · Also on Medicaid 55% · Health risk score 3.03. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Heart failure 75% · Diabetes 63% · Coronary heart disease 61% · Chronic kidney disease 61% · Atrial fibrillation 60% · COPD 57% · Depression 35% · Stroke 26% · Dementia 20%.
The office billed $64,093, Medicare allowed $21,794 and paid $17,232; for 231 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 82 | 231 | 76 | 3.03 | $64,093 | $17,232 |
| 2023 | 101 | 213 | 76 | 2.83 | $70,328 | $17,543 |
| 2022 | 219 | 539 | 73 | 2.74 | $165,603 | $39,460 |
| 2021 | 377 | 1,096 | 74 | 2.48 | $342,057 | $95,268 |
| 2020 | 446 | 1,306 | 73 | 2.62 | $435,042 | $116,152 |
| 2019 | 445 | 1,498 | 73 | 2.61 | $512,344 | $135,895 |
| 2018 | 407 | 1,292 | 73 | 2.53 | $409,319 | $110,073 |
| 2017 | 316 | 960 | 72 | 2.60 | $298,952 | $82,567 |
| 2016 | 119 | 241 | 72 | 2.53 | $72,411 | $19,072 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $5,850 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,624 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,429 | $101 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $687 | $57 |
2022: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $9,057 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $8,962 | $64 |
| Return visit (30+ min) | 36 | $3,624 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,839 | $177 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $2,053 | $187 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 29 | $1,843 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,811 | $121 |
| Short return visit (20+ min) | 32 | $1,704 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $166 | $13 |
2021: 14 services
| Return visit (30+ min) | 109 | $21,800 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 119 | $11,675 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $11,579 | $93 |
| Short return visit (20+ min) | 103 | $9,371 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $9,141 | $183 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 30 | $6,304 | $203 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 49 | $3,159 | $64 |
| New patient visit (45+ min) | 18 | $2,854 | $159 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,758 | $125 |
| Ultrasound of heart | 13 | $1,949 | $150 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,675 | $67 |
| Heart muscle strain imaging | 24 | $1,052 | $42 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 13 | $651 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 31 | $417 | $13 |
2020: 17 services
| Return visit (30+ min) | 137 | $24,165 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 159 | $18,131 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $11,038 | $187 |
| Short return visit (20+ min) | 99 | $8,615 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $7,391 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 32 | $6,641 | $208 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 92 | $6,425 | $68 |
| New patient visit (45+ min) | 37 | $5,524 | $149 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $4,456 | $131 |
| Ultrasound of heart | 29 | $4,382 | $137 |
| Injection, perflutren lipid microspheres, per ml | 20 | $1,517 | $38 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,478 | $70 |
| New patient visit (30+ min) | 12 | $1,184 | $99 |
| Heart muscle strain imaging | 22 | $970 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 38 | $727 | $17 |
| External ekg recording for more than 48 hours up to 21 days | 19 | $587 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 18 | $494 | $25 |
2019: 17 services
| Return visit (30+ min) | 154 | $36,136 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 167 | $22,002 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $16,620 | $179 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 63 | $13,348 | $202 |
| Short return visit (20+ min) | 107 | $9,111 | $65 |
| New patient visit (45+ min) | 58 | $8,843 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $5,822 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $3,118 | $115 |
| Initial hospital observation care per day, typically 70 minutes | 18 | $3,012 | $167 |
| New patient visit (30+ min) | 14 | $1,325 | $95 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 58 | $994 | $16 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $812 | $35 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $807 | $67 |
| Short return visit (20+ min) | 12 | $692 | $46 |
| Injection, perflutren lipid microspheres, per ml | 12 | $684 | $38 |
| External ekg recording for more than 48 hours up to 21 days | 15 | $496 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 11 | $316 | $24 |
2018: 13 services
| Return visit (30+ min) | 109 | $24,387 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 167 | $22,365 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $11,637 | $162 |
| Short return visit (20+ min) | 93 | $9,714 | $63 |
| New patient visit (45+ min) | 49 | $7,262 | $148 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 31 | $6,267 | $202 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $4,960 | $118 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 63 | $4,219 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $3,520 | $93 |
| Initial hospital observation care per day, typically 50 minutes | 13 | $1,449 | $111 |
| New patient visit (30+ min) | 13 | $1,303 | $100 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $1,038 | $35 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 42 | $745 | $16 |
2017: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 136 | $17,315 | $63 |
| Return visit (30+ min) | 79 | $13,923 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,941 | $175 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 37 | $7,323 | $198 |
| Short return visit (20+ min) | 76 | $6,955 | $63 |
| New patient visit (45+ min) | 46 | $6,797 | $148 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,769 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,377 | $88 |
| Initial hospital observation care per day, typically 50 minutes | 15 | $1,760 | $117 |
| New patient visit (30+ min) | 15 | $1,476 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 19 | $1,128 | $56 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $853 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 46 | $732 | $16 |
| Follow-up observation care per day, typically 25 minutes | 11 | $704 | $64 |
2016: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $3,472 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,344 | $117 |
| Return visit (30+ min) | 15 | $1,827 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 27 | $1,548 | $55 |
| Short return visit (20+ min) | 16 | $1,068 | $63 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $539 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $247 | $15 |
Medicaid work
$1,049 in 2021
Medicaid paid $1,049 for 41 billed services this clinician did in 2021, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 41 | $1,049 |
| 2021 | 41 | 1 | 16 | $1,049 |
| 2020 | 94 | 2 | 14 | $3,077 |
| 2019 | 308 | 3 | 24 | $9,910 |
| 2018 | 50 | 1 | 13 | $1,679 |
See the largest Medicaid services in earlier years
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 81 | $2,906 |
| Return visit (30+ min) | 13 | $171 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 282 | $8,678 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 12 | $745 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $486 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 50 | $1,679 |
Drugs they prescribed that Part D paid
$2,161
Pharmacies billed $2,161 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 87) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
85 generic and fewer than 11 brand-name prescriptions · $2,161 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Carvedilol | 12 | $211 | $18 |
Year by year
| 2024 | 87 | 30 | 0% (0) | None | $2,161 |
| 2023 | 204 | 67 | 0% (0) | 6% | $22,464 |
| 2022 | 1,054 | 192 | 0% (0) | 13% | $129,009 |
| 2021 | 1,545 | 212 | 0% (0) | 13% | $162,044 |
| 2020 | 1,533 | 218 | 0% (0) | 16% | $147,147 |
| 2019 | 1,495 | 215 | 0% (0) | 15% | $116,630 |
| 2018 | 1,152 | 182 | None | None | $83,025 |
| 2017 | 506 | 92 | None | 25% | $27,820 |
| 2016 | 92 | 30 | 0% (0) | 12% | $3,545 |
| 2015 | 175 | 38 | None | 11% | $6,747 |
| 2014 | 208 | 57 | 0% (0) | 24% | $12,811 |
| 2013 | 58 | 25 | None | None | $1,900 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Atorvastatin | 38 | $607 | $16 |
| Carvedilol | 27 | $514 | $19 |
| Losartan | 19 | $311 | $16 |
| Amlodipine Besylate | 18 | $216 | $12 |
| Metoprolol | 12 | $176 | $15 |
2022: 21 drugs
| Xarelto | 42 | $51,808 | $1,234 |
| Eliquis | 45 | $33,023 | $734 |
| Brilinta | 13 | $5,911 | $455 |
| Atorvastatin | 159 | $1,906 | $12 |
| Ezetimibe | 22 | $1,587 | $72 |
| Metoprolol | 85 | $1,353 | $16 |
| Diltiazem 24hr Er (Cd) | 11 | $1,221 | $111 |
| Carvedilol | 89 | $1,101 | $12 |
| Amlodipine Besylate | 81 | $642 | $8 |
| Losartan | 50 | $629 | $13 |
| Mirtazapine | 14 | $601 | $43 |
| Amiodarone | 14 | $592 | $42 |
| Clopidogrel | 32 | $590 | $18 |
| Lisinopril | 53 | $401 | $8 |
| Spironolactone | 41 | $331 | $8 |
| Rosuvastatin | 19 | $239 | $13 |
| Furosemide | 52 | $236 | $5 |
| Pravastatin | 11 | $231 | $21 |
| Amlodipine Besylate-Benazepril | 13 | $147 | $11 |
| Simvastatin | 14 | $79 | $6 |
| Hydrochlorothiazide | 26 | $43 | $2 |
2021: 30 drugs
| Xarelto | 64 | $70,313 | $1,099 |
| Eliquis | 47 | $34,641 | $737 |
| Entresto | 26 | $15,766 | $606 |
| Atorvastatin | 188 | $2,418 | $13 |
| Metoprolol | 133 | $2,171 | $16 |
| Ezetimibe | 24 | $1,490 | $62 |
| Carvedilol | 108 | $1,374 | $13 |
| Diltiazem 24hr Er (Cd) | 13 | $1,272 | $98 |
| Bumetanide | 11 | $1,246 | $113 |
| Losartan | 63 | $1,028 | $16 |
| Valsartan | 20 | $940 | $47 |
| Amlodipine Besylate | 156 | $805 | $5 |
| Amiodarone | 31 | $726 | $23 |
| Lisinopril | 82 | $603 | $7 |
| Spironolactone | 73 | $551 | $8 |
| Clopidogrel | 30 | $491 | $16 |
| Rosuvastatin | 16 | $442 | $28 |
| Amlodipine Besylate-Benazepril | 20 | $408 | $20 |
| Losartan-Hydrochlorothiazide | 13 | $395 | $30 |
| Pravastatin | 20 | $376 | $19 |
| Furosemide | 81 | $363 | $4 |
| Isosorbide Mononitrate Er | 14 | $349 | $25 |
| Hydralazine | 22 | $311 | $14 |
| Dilt-Xr | 12 | $282 | $24 |
| Ramipril | 11 | $260 | $24 |
| Simvastatin | 28 | $160 | $6 |
| Hydrochlorothiazide | 44 | $148 | $3 |
| Omeprazole | 11 | $146 | $13 |
| Metoprolol | 16 | $110 | $7 |
| Lisinopril-Hydrochlorothiazide | 15 | $107 | $7 |
2020: 28 drugs
| Xarelto | 69 | $66,909 | $970 |
| Eliquis | 35 | $28,969 | $828 |
| Brilinta | 15 | $6,516 | $434 |
| Metoprolol | 132 | $3,149 | $24 |
| Atorvastatin | 184 | $2,689 | $15 |
| Ezetimibe | 21 | $2,516 | $120 |
| Olmesartan Medoxomil | 23 | $1,823 | $79 |
| Rosuvastatin | 25 | $1,653 | $66 |
| Flecainide Acetate | 20 | $1,457 | $73 |
| Carvedilol | 99 | $989 | $10 |
| Amlodipine Besylate | 174 | $975 | $6 |
| Bumetanide | 16 | $858 | $54 |
| Losartan | 61 | $829 | $14 |
| Valsartan | 22 | $715 | $33 |
| Lisinopril | 107 | $628 | $6 |
| Diltiazem 24hr Er (Cd) | 18 | $608 | $34 |
| Furosemide | 88 | $596 | $7 |
| Pravastatin | 29 | $496 | $17 |
| Clopidogrel | 27 | $430 | $16 |
| Spironolactone | 47 | $376 | $8 |
| Lovastatin | 13 | $342 | $26 |
| Hydrochlorothiazide | 45 | $325 | $7 |
| Dilt-Xr | 12 | $181 | $15 |
| Simvastatin | 19 | $158 | $8 |
| Benazepril | 22 | $123 | $6 |
| Omeprazole | 14 | $97 | $7 |
| Metoprolol | 21 | $89 | $4 |
| Clonidine | 11 | $35 | $3 |
2019: 27 drugs
| Xarelto | 75 | $44,624 | $595 |
| Eliquis | 63 | $43,523 | $691 |
| Metoprolol | 121 | $3,218 | $27 |
| Atorvastatin | 161 | $2,670 | $17 |
| Olmesartan Medoxomil | 32 | $2,366 | $74 |
| Amlodipine Besylate | 168 | $1,251 | $7 |
| Carvedilol | 91 | $946 | $10 |
| Rosuvastatin | 14 | $859 | $61 |
| Lisinopril | 146 | $849 | $6 |
| Clopidogrel | 44 | $648 | $15 |
| Losartan | 65 | $642 | $10 |
| Propranolol | 14 | $607 | $43 |
| Furosemide | 82 | $568 | $7 |
| Flecainide Acetate | 24 | $543 | $23 |
| Isosorbide Mononitrate Er | 15 | $505 | $34 |
| Hydrochlorothiazide | 60 | $406 | $7 |
| Pravastatin | 21 | $406 | $19 |
| Chlorthalidone | 17 | $353 | $21 |
| Ramipril | 11 | $338 | $31 |
| Hydralazine | 15 | $303 | $20 |
| Spironolactone | 32 | $288 | $9 |
| Dilt-Xr | 12 | $202 | $17 |
| Simvastatin | 17 | $199 | $12 |
| Lovastatin | 14 | $164 | $12 |
| Warfarin | 11 | $97 | $9 |
| Benazepril | 14 | $91 | $6 |
| Metoprolol | 13 | $74 | $6 |
2018: 21 drugs
| Eliquis | 54 | $34,770 | $644 |
| Xarelto | 26 | $16,217 | $624 |
| Brilinta | 31 | $14,773 | $477 |
| Metoprolol | 70 | $1,859 | $27 |
| Atorvastatin | 131 | $1,788 | $14 |
| Amlodipine Besylate | 132 | $909 | $7 |
| Carvedilol | 109 | $773 | $7 |
| Lisinopril | 97 | $644 | $7 |
| Losartan | 56 | $549 | $10 |
| Potassium Chloride | 11 | $534 | $49 |
| Rosuvastatin | 11 | $500 | $45 |
| Pravastatin | 29 | $413 | $14 |
| Furosemide | 85 | $375 | $4 |
| Hydrochlorothiazide | 49 | $321 | $7 |
| Hydralazine | 18 | $303 | $17 |
| Isosorbide Mononitrate Er | 14 | $286 | $20 |
| Clopidogrel | 23 | $215 | $9 |
| Atenolol | 23 | $166 | $7 |
| Simvastatin | 11 | $137 | $12 |
| Benazepril | 16 | $128 | $8 |
| Metoprolol | 21 | $59 | $3 |
2017: 9 drugs
| Eliquis | 20 | $10,312 | $516 |
| Metoprolol | 51 | $1,615 | $32 |
| Atorvastatin | 89 | $1,204 | $14 |
| Carvedilol | 55 | $414 | $8 |
| Lisinopril | 40 | $237 | $6 |
| Clopidogrel | 16 | $182 | $11 |
| Furosemide | 36 | $169 | $5 |
| Amlodipine Besylate | 31 | $123 | $4 |
| Spironolactone | 14 | $62 | $4 |
2016: 3 drugs
| Atorvastatin | 13 | $222 | $17 |
| Furosemide | 16 | $89 | $6 |
| Lisinopril | 14 | $60 | $4 |
2015: 7 drugs
| Atorvastatin | 30 | $461 | $15 |
| Clopidogrel | 23 | $229 | $10 |
| Metoprolol | 11 | $178 | $16 |
| Pravastatin | 12 | $161 | $13 |
| Carvedilol | 15 | $52 | $3 |
| Furosemide | 14 | $34 | $2 |
| Lisinopril | 11 | $32 | $3 |
2014: 8 drugs
| Eliquis | 13 | $3,837 | $295 |
| Metoprolol | 28 | $700 | $25 |
| Amiodarone | 14 | $519 | $37 |
| Atorvastatin | 20 | $323 | $16 |
| Carvedilol | 15 | $114 | $8 |
| Lisinopril | 18 | $79 | $4 |
| Furosemide | 18 | $50 | $3 |
| Metoprolol | 13 | $47 | $4 |
Money from drug and device companies
$144 in 2025
| 2025 | 2 | 2 | None | $144 |
| 2022 | 1 | 2 | None | $49 |
| 2021 | 2 | 6 | None | $1,027 |
| 2020 | 3 | 5 | None | $279 |
| 2019 | 4 | 9 | None | $711 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abiomed | None | $125 | 1 payment
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $19 | 1 payment
|
See all 2 published payments
| Baxter Healthcare | Meals · 2025-08-27 | Hillrom - Carnation Ambulatory Monitor | $19 |
| Abiomed | Meals · 2025-03-29 | None | $125 |
See earlier years (2022, 2021, 2020, 2019)
2022: $49
| Biotronik | Edora 8 Dr-T | $49 | 2 payments
|
2021: $1,027
| Medtronic | Micra | $956 | 5 payments
|
| Biotronik | Solia | $71 | 1 payment
|
2020: $279
| Biotronik | None | $161 | 2 payments
|
| Medtronic Vascular | Reveal Linq | $95 | 2 payments
|
| Preventice Services | None | $23 | 1 payment
|
2019: $711
| Biotronik | None | $350 | 5 payments
|
| Abbott Laboratories | Accent Pacemaker | $204 | 2 payments
|
| Medtronic Vascular | Reveal Linq | $145 | 1 payment
|
| iRhythm Technologies | Zio Patch | $12 | 1 payment
|
Professional record
- NPI
- 1316189053
- Licence
- CA A126257California A126257: Current · expires 2027-04-30
- Trained
- University of Virginia School of Medicine, 2009 · 17 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 3687 Mt Diablo Blvd, Suite 200, Lafayette, CA, 94549
- NPI first listed
- 2009-03-26
- NPI last updated
- 2016-09-26
This is when the NPI record was last certified, not a medical board exam.